
Cellular immunotherapy development firm Cell Medica has confirmed the completion a £50 million investment round from key backers to progress …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

